Cadonilimab (Anti-PD-1 & CTLA-4)

製品コード：A4002 Batch: A400201

Cadonilimab is a humanized tetravalent bispecific IgG1 antibody targeting human PD-1 and CTLA-4 with potential immune checkpoint inhibitory and antineoplastic activities. It has the potential to treat recurrent or metastatic cervical cancer. MW : 198.64 KD.

製品説明

CAS No.	2394841-59-7
Source	CHO
Storage (From the date of receipt)	-80℃(avoid freeze-thaw cycles)
Shipping	Shipped under low temperature conditions
Purity	99%
Protein concentration	6.881mg/ml
Endotoxin Level	＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。